Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorry but this is incorrect. One order is one commission if it is a good till canceled order there will still be just one commission even if it takes many small lots over up to 6 months the usual period covered by the good till canceled order. A commission is paid on the first lot the rest are paid for by that commission.
According to FINRA REGULATIONS one must hold $2.50 cash or marginal securities in one's account for each share shorted even if the stock is trading at less than a penny per share. Unless one's account has a value of more than $25 million dollars. So do the math on who the short sellers might be. Certainly not the 24/7 naysayers on this board as they for the most part speak negatively about this one stock where the large short funds hold short and trade from the short side on whole baskets of small stocks in accounts of more than $25 million. Their protection lay in diversification as is more likely that these small Biotechs suffer through precipitous drops rather than meteoric assent.
Nice! Excuse my ignorance but what is the rational of using All or Nothing orders?
Interestingly the good Doctor writes; ."..WHEN the FDA approves DC-Vax" not IF the FDA approves DC-Vax.
Interestingly this chart seems that it could trace out a 7 year "Cup with Handle" formation. The $10.00 SP technically could be achieved in 18 months or less.
A bull flag would indicate the possible 1 for 1 recreation or mirror of the first flag pole taking the stock price to $3.50ish before any appreciable consolidation.
I am not horrorfied but chagrined that he mentioned NWBO. He has mentioned NWBO in the past I believe so not really surprised. NWBO will certainly get more respectable coverage soon.
Double the average volume today. NWBO might double today's volume tomorrow. Nothing draws eyes like 16% upswing.
NWBO was hard to buy today at anything but the ASK. Nevertheless I added a few boat loads between .77 and .78 by hitting the ASK.
Thank you. Yes that is Definately a breakout in Google search as well as the related topics.
Well played Sir.
The Journal Article will be superfluous after Manufacturing and marketing approval in the UK.
Get F'ing real! NWBO is held by serious well healed retail high intelligent well informed investors not get rich quick Meme Stock Traders. If these new revealed Science presentation do not add to the share price we will aggressively accumulate prior to the almost certainty of Up List, Partnership and Approval . All one needs now is patience. Book it!
Sorry I investigated shows 29 hits. Which is more than days before but not significant. I call BS. There is no short cut to proper DD. We are here because of our knowledge not google trends which might work for stocks like Tesla or Meme stocks like GME or AMC. THERE IS NO GOOGLE TREND ON NWBO.
We will win on SCIENCE AND MEDICAL COMMUNITY ACCEPTANCE not on Meme stock status.
I call bull on Google trends after investigation..
It means retail is clueless as to value of OTLK. Do you own this stock or you a troll?
I definately agree with this. Trading only to allocate between taxable and tax advantaged accounts and capturing loses to reestablish the position after 30 days.
Holding a lot of cash to deploy to buy in a short attack should it happen.
I think many are doing the same and already have large holdings.
After a big jump in share price many retail will sell out of the deadly disease that afflicts retail investors that I call "Getbacktoevenitis"
As you observe Institution will start to accumulate and price will rise in fits and starts for a long time. After Approval the risk shifts to execution risk and the reward part of the equation is growth prospects.
Thanks for this post of Annie's tweet. This is a self evident and and obvious if simplistic reflection on the the Market Cap potential of NWBO. Also reference the recent Gilead $20 billion buyout of a pre-revenue cancer biotechnology company.
Any event that puts $20 million in NWBO coffers will allow NWBO to Up List to a major exchange which could result in a 20x stock revaluation within 18 months.
The numbers and logic speak for themselves.
This is an astute observation.
Woodford's comment to The Times reminds me of Aesop's fable of the fox and the grapes which proved to be out of it's reach.
I assume your numbers come from "Google Analytics" Do you mind educating us on how to veiw the Google Analytics information on the Search Term "Northwest Biologics"
Ticking time bomb for those holding NWBO short. More like sweating dynamite in that anything could set off an explosion in the stock price. Often times as a Stock approaches a water shed binary event the price explodes on no obvious trigger before the event.
NWBO has to bid there time im respect to bringing legal actions. Lies must be squarely refuted by RA approvals. Then the weight of evidence and burden shifts somewhat as to damages but a high burden of proof remains with Plaintiff NWBO. But if market cap goes up 5 or 10x LP her self could fund litigation which I would characterize as a S.L.A.P suit. In other words but the Defendants in such a peril of devistatingly large damages even though a small percent of victory. War of attrition so costly to the Defendants in legal fees alone that according to Nash Game Theory the Defendants would 1) S.T.F.U. and 2) possibly "roll over" on co-defendant by providing information in the discovery process that tends to exonerate those Defendants by implicating other more guilty Defendants. A.F has been brought to trial in the past and always escaped like he was Teflon coated. John Gotti as well until it finally stuck. Of cowards note that amongst them will usually be a rat anxious to save its skin.
Astute observation. Thanks.
All the stock of this company is owned by Institutions 113% 13.83 % short. Short sellers are betting against the super well funded uber diamond hands. Supply demand will go asymmetrical approaching the vertical. I am glad you are here. Not a lot of retail to post when the big boys own all of the shares and hold all of the shorted shares long. How will short sellers cover if Institutions Diamond Hand. (Which is what they ALWAYS DO!)
Any Gap above $2.50 if breakaway gap should start a run. Market recognition might get triggered before SNO or after. In my experience these usually come out of the blue on no news at all that is evident to the public. That is why I describe these events as "Blue Sky Tornados" for the way price rises and suddenness they are triggered.
Well now that was then this is now. Bravo to the shorts,well played. However if one can not close out the short position now one might very well be Eff You Sea Kay'd.
Gary, I agree NWBO might have a widely applicable platform technology in the personalized biologic manufacturing space analogous to Illumina in the genome sequencing space. That is the say virtually occupying 90% of the market.
Well articulated. I would hope to have responded similarly if I had the stomach to read the oft repeated drivel you are responding to. My position entirely. No short cuts for NWBO the same as there are no shortcuts for succesful investing. It takes years for the development to mature.
One might with proper perspective judge these types of investments with the realization that Management and the Scientists have invested more than money in these ventures but much of the their careers. So the question becomes; does the work of the Scientists have merit and does the work of Management dutifully support the work of the scientists. How one qualifies these things are up to each individual investor or fund. A few great investments are undervalued by "Wall Street" on these types of investments. Why is that? Because very simply "WALL STREET" does not have the shares to sell to the public. When the opportunity is well known and proven Wall STREET participates in Secondary Stock Offers and then lauds and publicized the great opportunity until the Stock is overvalued then it goes into the "Distribution Phase' where Wall Street sell this sure fire Investments the public and other funds designed to preserve capital.
Wall Street will not comment on or rate Investments their Clients do not own. Simple. John Nash Game Theory.
NWBO is in, in my opinion the 'Accumulation Phase' which will proceed in earnest after Up List and Secondary Offering. At some point the Quants will overvalue NWBO but not until the Institutions own most of the Stock.
One should pay attention with whom they are investing with at this early Stage. Linda Powell CEO is heavily invested and we also have Angel Types like Robert Heafner III who got in early and Big. Look and Listen.
Looks like Outlook is firing up for a run.
100% agree these high-risk/high-reward Biotech's have a propensity to flash-over with 10-25x market cap appreciation over about 18 months from when they start the run. Anavex Life Sciences run from below $200 million market cap to peak at over $1.7 billion in a period of 18 months. A year or two prior to that Arrowhead Research flashed over from less than $200 million to over $7.0 billion market cap in less than 18 months. Gene Silencing tech. Arrowhead still has a market cap over $3 billion so might be finished with early stage flashovers in market recognition revaluation.
NWBO addresses a much larger indication/treatment market than Arrowhead therefore might run higher as Arrowhead indicatitions are rare diseases. NWBO could also flashover more quickly and violently to the upside due to certain dynamics it the way NWBO is setting up.
Arrowhead is an amazing company. Gene silencing is a world away from gene editing.
As far as I am concerned if one is to actively trade then one should not be too considered with the company only the "ticker" and its momentum and technicals. On the other hand an Investor might look only at the business of the company and invest accordingly adding to one's position over many years or at least many months with at the very least a 5 year time horizon for the company to advance.
I know you do not share my belief of Government and RA corruption. I think that is an unintended consequence of the Prescription Drug User Fee Act. Corruption unintentional invited by Statute.
The future of NWBO is connected to the less corrupted yet more chaotic UK MNRA. After the total failure of the FDA, CDC and NIH in the USA in relation to Sars Covid 2 one can measure the magnitude of the PDUFA in relation to that failure. It has been recognized for centuries that "The Ones Who Pay the Piper Calls the Tunes"
According to FINRA REGULATIONS only the stocks above $2.00 can be used as margin collateral. Then only the value of the stock over the $2.00 threshold can be added to the margin pool. As example a $3.00 would allow $1 for margin pool.
Similarly cash requirements for accounts less than $25 million in value to short a stock one needs to hold cash of $2.50 per share short sold even if $0.01 or less. So if you suspect your penny stock is being shorted then it shorted by accounts valued at $25 million or more. The big money rules the roost and can manipulate stock prices with impunity. The system is designed in my opinion to favor big accounts and cripple small ones to allow big accounts to crush retail that dares to trade instead of long term investment.
Fact checked. Not true. There will be no temporary ticker change it will be USOI but with a new cupid number. Can trade it immediately.
This is a simple question. If one is long they feel NWBO under valued. If short they know it is undervalued but also misunderstood and unrecognized by the market. The four types of stock recognion are:
a) over recognized
b) fairly recognized
c) under recognized
d) not recognized at all in the public markets
Imagine the increase in market cap as a Company rises from d) to a) or b) in market recognition.
Kristen Powers is not Related to Linda Powers. I do not imply that you implied that just clarification.
This post is 100% truth.
I believe this to be correct. It also explains the phenomenon that many times the hockey stick market cap and up gaps in biotechs occur before regulatory approvals. Most often they occur on Trial Results PRs. Which triggers market recognition of the potential which of course drastically increases the market cap very quickly sometimes in a matter of days.
This is exactly right. The demand will be off the charts.